Laboratory Medicine
9.5K views | +0 today
Follow
 
Scooped by Gilbert C FAURE
onto Laboratory Medicine
April 22, 12:52 PM
Scoop.it!

First Long COVID test to launch in UK and EU

First Long COVID test to launch in UK and EU | Laboratory Medicine | Scoop.it
The first test to diagnose Long COVID is due to launch in the UK and EU as a result of a collaboration between two health tech companies, PeploBio and IncellDX.
No comment yet.
Laboratory Medicine
Laboratory Medicine
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
December 28, 2013 2:29 AM
Scoop.it!

Laboratory Medicine and Medical Biopathology

 

Laboratory Medicine is the name of a medical specialty where specialists are involved in medical diagnosis using laboratory assays to characterize molecular and cellular parameters in blood, biological fluids and tissues;

It is called also clinical pathology.

 

Gilbert C FAURE's insight:

covering disciplines such as

 

(Biochemistry http://www.scoop.it/search?q=biochemistry)

 

Haematology

http://www.scoop.it/t/hematology

 

(Microbiology http://www.scoop.it/search?q=microbiology )

 

Immunology

http://www.scoop.it/t/immunology

 

(Genetics http://www.scoop.it/search?q=genetics)

some already covered by the curator of this topic

 

check also

http://www.scoop.it/t/autoimmunity

for autoimmune diseases diagnostic tools

 

CHECK for COVID-19

https://www.scoop.it/topic/medical-biopathology-and-laboratory-medicine/?&tag=covid-19

more than 100 relevant papers on tests, either serological, cellular...

 

 

No comment yet.
Scooped by Gilbert C FAURE
December 7, 2:54 AM
Scoop.it!

Analytical considerations for detecting and quantifying novel synthetic opioids, including ‘nitazenes’, in biological samples

Analytical considerations for detecting and quantifying novel synthetic opioids, including ‘nitazenes’, in biological samples | Laboratory Medicine | Scoop.it
Overview

In recent years, novel synthetic opioids (NSOs) have been detected in drug seizures and in biological samples in the United Kingdom. These compounds are highly potent, and so keeping current with which compounds are in circulation in the illicit drug market in the UK, and how best to det
No comment yet.
Scooped by Gilbert C FAURE
November 24, 11:07 AM
Scoop.it!

Laboratory Medicine - Case #1 | Traces of blood on urine dipstick

usmlestep1 #usmlepreparation Laboratory Medicine | Traces of blood on urine dipstick Get the full book: https://amzn.to/4fTTKEZ ...
No comment yet.
Scooped by Gilbert C FAURE
November 12, 4:36 AM
Scoop.it!

Revolutionizing Cytology and Cytopathology with Natural Language Processing and Chatbot Technologies: A Narrative Review on Current Trends and Future Directions

Revolutionizing Cytology and Cytopathology with Natural Language Processing and Chatbot Technologies: A Narrative Review on Current Trends and Future Directions | Laboratory Medicine | Scoop.it
The application of chatbots and Natural Language Processing (NLP) in cytology and cytopathology is an emerging field, which is currently characterized by a limited but growing body of research. Here, a narrative review has been proposed utilizing a standardized checklist and quality control...
No comment yet.
Scooped by Gilbert C FAURE
September 13, 3:48 AM
Scoop.it!

Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology ...

Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology ... | Laboratory Medicine | Scoop.it
Abstract. The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the p
No comment yet.
Scooped by Gilbert C FAURE
August 3, 5:19 AM
Scoop.it!

Favoriser l’accès aux actes innovants : la HAS impulse un nouvel élan au RIHN

Favoriser l’accès aux actes innovants : la HAS impulse un nouvel élan au RIHN | Laboratory Medicine | Scoop.it
La HAS a été saisie par le ministère chargé de la Santé pour évaluer des actes onéreux inscrits sur le référentiel des actes innovants hors nomenclature (RIHN), en vue de leur prise en charge de droit commun. En contribuant activement à relancer le caractère dynamique de cet outil de soutien à l’innovation, la HAS confirme son engagement à favoriser un accès précoce et équitable des patients à l’innovation en santé.
Gilbert C FAURE's insight:

so late

No comment yet.
Scooped by Gilbert C FAURE
July 20, 8:48 AM
Scoop.it!

– Laboratory Medicine at the Clinical Interface ©

– Laboratory Medicine at the Clinical Interface © | Laboratory Medicine | Scoop.it
No comment yet.
Scooped by Gilbert C FAURE
June 6, 1:20 PM
Scoop.it!

U.S. Clinical Laboratory Tests Market Share, Size and Industry Growth Analysis 2020 - 2025

U.S. Clinical Laboratory Tests Market Share, Size and Industry Growth Analysis 2020 - 2025 | Laboratory Medicine | Scoop.it
U.S. Clinical Laboratory Tests Market Size, Share, Trends and industry analysis now available from IndustryARC. Report reveals U.S. Clinical Laboratory Tests Market in the industry by Type, Products and Application.
No comment yet.
Scooped by Gilbert C FAURE
May 28, 1:30 PM
Scoop.it!

Juan Lama on LinkedIn: #covid19 #influenza #rsv #mpox #hmpv #piv #norovirus #rotavirus #stanford…

Juan Lama on LinkedIn: #covid19 #influenza #rsv #mpox #hmpv #piv #norovirus #rotavirus #stanford… | Laboratory Medicine | Scoop.it
Probably the best Public Health tool available in the US to track near real-time the circulation of multiple infectious diseases by monitoring wastewater…
No comment yet.
Scooped by Gilbert C FAURE
April 30, 3:55 AM
Scoop.it!

ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices

ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices | Laboratory Medicine | Scoop.it
ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.
No comment yet.
Scooped by Gilbert C FAURE
April 29, 10:35 AM
Scoop.it!

Direct-to-consumer testing – benefits for consumers, people with disease and public health

Direct-to-consumer testing – benefits for consumers, people with disease and public health | Laboratory Medicine | Scoop.it
Direct-to-consumer (DTC) tests can be defined as any in-vitro diagnostic (IVD) test or, more broadly, any medical test using an IVD or medical device, that is marketed directly to consumers without involvement of a health care provider (HCP). Examples are pregnancy tests, alcohol breath tests, blood pressure measurements (medical device), coagulation tests (INR), self-monitoring of blood glucose, continuous glucose monitoring (medical device), HIV tests, HPV tests, SARS-CoV-2 antigen tests, or genetic tests. DTC tests fulfil various customer needs such as making rapid decisions (e.g. glucose monitoring for insulin dosing, SARS-CoV-2 antigen test, hormone test identifying fertile days, alcohol test), monitoring chronic conditions between consultations (e.g. diabetes, lipidaemia, hypertension), saving time and reducing consultations (e.g. INR, SARS-CoV-2 antigen test, blood pressure monitoring), screening for disease when no symptoms are present (e.g. occult blood, cholesterol, triglycerides, SARS-CoV2 antigen test), or maintaining privacy (e.g. pregnancy test, HIV test, HPV test, certain genetic tests). Further, DTC tests can reduce cost and expand access to care in countries with limited resources and can support healthcare systems in extraordinary circumstances such as a pandemic. Valid concerns about DTC testing need to be described, addressed and resolved with the help of authorities and regulators in collaboration with HCP and should not detract from the advantages DTC tests can provide. HCP should play a more prominent role in educating the public through mass media and social media on the proper use of DTC tests and help to pinpoint problem areas.
No comment yet.
Scooped by Gilbert C FAURE
April 29, 10:29 AM
Scoop.it!

direct-to-consumer-genetic-testing.pdf

Gilbert C FAURE's insight:

a black box!

No comment yet.
Scooped by Gilbert C FAURE
April 28, 12:50 PM
Scoop.it!

Cancer screening with multicancer detection tests: A translational science review - Rubinstein - CA: A Cancer Journal for Clinicians - Wiley Online Library

<em>CA: A Cancer Journal for Clinicians</em> is ACS' flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
No comment yet.
Scooped by Gilbert C FAURE
Today, 3:48 AM
Scoop.it!

Ramanan Laxminarayan on LinkedIn: Lab capacity in Africa | 15 comments

Ramanan Laxminarayan on LinkedIn: Lab capacity in Africa | 15 comments | Laboratory Medicine | Scoop.it
Our analysis of laboratory capacity for AMR is finally out this week in The Lancet Microbe. The headlines from this analysis has already found its way into… | 15 comments on LinkedIn
No comment yet.
Scooped by Gilbert C FAURE
November 30, 2:25 AM
Scoop.it!

Le classement ECN des spécialités 2024, quelles sont les spés préférées ? Et les négligées ?

Le classement ECN des spécialités 2024, quelles sont les spés préférées ? Et les négligées ? | Laboratory Medicine | Scoop.it
Le classement ECN des spécialités 2024, quelles sont les spés préférées ? Et les négligées ? - Depuis la réforme des ECN, adieu le classement unique, on le sait, désormais il existe 13 classements différents, regroupant les 44 spécialités. Néanmoins il est toujours intéressant de connaître les spécialités en tension, celles qui sont choisies en priorité ou au contraire, celles qui sont boudées. Voici le classement des spécialités 2024, établi par L’Etudiant.
No comment yet.
Scooped by Gilbert C FAURE
November 21, 5:02 AM
Scoop.it!

Radiometer on LinkedIn: Microsoft Virtual Events Powered by Teams

Radiometer on LinkedIn: Microsoft Virtual Events Powered by Teams | Laboratory Medicine | Scoop.it
Rejoignez-nous le 3 décembre 2024 pour un webinaire dédié à l'accréditation et aux gaz du sang, animé par l'expert Professeur Damien Bouvier, médecin…
No comment yet.
Scooped by Gilbert C FAURE
August 15, 2:39 AM
Scoop.it!

RWS Group on LinkedIn: MDR & IVDR vs pharma regulations: Structural blindspots in the regulations

RWS Group on LinkedIn: MDR & IVDR vs pharma regulations: Structural blindspots in the regulations | Laboratory Medicine | Scoop.it
The introduction of MDR & IVDR indicates a shift EU medical device regulation, now and in the future. We discuss the recent changes and the potential future…
No comment yet.
Scooped by Gilbert C FAURE
July 31, 4:24 AM
Scoop.it!

I feel sick. How do I know if I have the flu, COVID, RSV or something else?

I feel sick. How do I know if I have the flu, COVID, RSV or something else? | Laboratory Medicine | Scoop.it
You wake with a sore throat and realise you are sick. Is this going to be a two-day or a two-week illness? Here’s how to tell the difference between these common infections.
No comment yet.
Scooped by Gilbert C FAURE
July 11, 3:29 AM
Scoop.it!

Medical laboratory scientist motivation to pursue graduate education | Laboratory Medicine | Oxford Academic

Medical laboratory scientist motivation to pursue graduate education | Laboratory Medicine | Oxford Academic | Laboratory Medicine | Scoop.it
AbstractBackground. Medical laboratory staffing shortages have persisted, with challenges in maintaining adequate medical laboratory professionals. The car
No comment yet.
Scooped by Gilbert C FAURE
May 4, 8:24 AM
Scoop.it!

What you need to know about working as a lab professional in a different state

What you need to know about working as a lab professional in a different state | Laboratory Medicine | Scoop.it
If you are willing to relocate or travel, lab professional jobs exist nationwide. Here’s what you need to know about working in another state.
No comment yet.
Scooped by Gilbert C FAURE
April 29, 11:20 AM
Scoop.it!

https://www.360dx.com/regulatory-news-fda-approvals/fda-releases-final-rule-regulation-laboratory-developed-tests?utm_source=Sailthru&utm_medium=email&utm_campaign=360DN%20Mon%202024-04-29&utm_term...

No comment yet.
Scooped by Gilbert C FAURE
April 29, 10:31 AM
Scoop.it!

Direct-to-consumer laboratory testing (DTCT): challenges and implications for specialists in laboratory medicine

Direct-to-consumer laboratory testing (DTCT): challenges and implications for specialists in laboratory medicine | Laboratory Medicine | Scoop.it
In vitro diagnostics (IVD) testing is a powerful tool for medical diagnosis, and patients‘ safety is guaranteed by a complex system of personnel qualification of the specialist in laboratory medicine, of process control, and legal restrictions in healthcare, most of them under national regulation. Direct-to-consumer laboratory testing (DTCT) is testing ordered by the consumer and performed either by the consumer at home or analysis of self-collected samples in a laboratory. However, since DTCT are not always subject to effective competent authority oversight, DTCT may pose risks to lay persons using and relying on it for healthcare decision-making. Laboratory medicine specialists should be very cautious when new DTCTs are introduced. As qualified professionals, they should feel obliged to warn and educate patients and the public about the risks of inappropriate and harmful DTCT.
No comment yet.
Scooped by Gilbert C FAURE
April 29, 10:26 AM
Scoop.it!

What is direct-to-consumer genetic testing?: MedlinePlus Genetics

What is direct-to-consumer genetic testing?: MedlinePlus Genetics | Laboratory Medicine | Scoop.it
Direct-to-consumer genetic testing is done with tests bought online or in stores. It is sometimes called at-home genetic testing or home DNA testing. Learn more about these tests.
No comment yet.
Scooped by Gilbert C FAURE
April 26, 10:03 AM
Scoop.it!

Europe In Vitro Diagnostics Market Size to Increase USD 28.77 Bn by 2033

According to Vision Research Reports, the Europe in vitro diagnostics market size is calculated at USD 26.97 billion in 2024 and is expected to surpass around USD 28.77 billion by 2033, poised to grow at a CAGR of 0.72% from 2024 to 2033.
No comment yet.